Spark Therapeutics, a member of the Roche Group, has unveiled plans for a $575 million gene therapy innovation center in Philadelphia within Drexel University’s campus within the University City neighborhood.
iECURE Partners to Develop Next-Generation Liver-Targeted Lipid Nanoparticles with University of Pennsylvania - read this article along with other careers information, tips and advice on BioSpace
Partnership agreement includes exclusive rights in animal health to novel viral vector capsid and expands additional optionrights to novel capsids Next-generation novel adeno-associated viral (AAV) vector capsid promises enhanced manufacturabilityExpanded